11.06.2013 Views

Thursday-Abstracts

Thursday-Abstracts

Thursday-Abstracts

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Thursday</strong>, May 30, 2013<br />

S246 Vol. 45 No. 5 Supplement<br />

1271 Board #217 May 30, 8:00 AM - 9:30 AM<br />

Marine Lipid Fraction PCsO-524 (Lyprinol®/Omega<br />

XL®) attenuates airway Inflammation and hyperpnea-<br />

Induced Bronchoconstriction in asthmatic Individuals<br />

Timothy D. Mickleborough, FACSM, Cherissa L. Vaughn, Ren-<br />

Jay Shei, Eliza M. Davis, Jacob A. Sinex, David Platt, Daniel P.<br />

Wilhite. Indiana University, Bloomington, IN.<br />

(No relationships reported)<br />

It has previously been shown that fish oil supplementation, rich in the omega-3<br />

fatty acids (Ω3FAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid<br />

(DHA) can attenuate airway inflammation and exercise and hyperpnea-induced<br />

bronchoconstriction (EIB and HIB respectively) in elite athletes and asthmatics.<br />

PCSO-524 (Lyprinol®/Omega XL®) is a supplement extracted from the New<br />

Zealand green-lipped mussel (Perna Canaliculus) comprising 14 + 7% EPA and 11<br />

+ 7% DHA, and containing up to 22 times more fatty acids than regular fish oil. It<br />

has been shown that PCSO-524 can moderate airway inflammation in humans with<br />

asthma, and in a murine-model of allergic airway disease.<br />

PurPOsE: Evaluate the effect of PCSO-524 on airway inflammation and the<br />

bronchoconstrictor response to eucapnic voluntary hyperpnea (EVH) in asthmatics.<br />

METhOds: In this model of EIB twenty asthmatic subjects, with HIB, participated in<br />

a placebo controlled double-blind randomized crossover trial. Subjects entered the study<br />

on their usual diet and were then placed on 3 weeks of PCSO-524 (~56 mg EPA/day;<br />

~44 mg DHA/day) or placebo supplementation (olive oil), followed by a 2 week washout<br />

period, before crossing over to the alternative diet. Pre- and post-EVH pulmonary<br />

function, fraction of exhaled nitric oxide (F E NO), asthma symptom scores, medication<br />

use, exhaled breath condensate (EBC) pH, cysteinyl leukotrienes (cyst-LT), 8-isoprostane<br />

and urinary 9α, 11β-prostaglandin (PG)F 2 and Clara (CC16) protein concentrations were<br />

assessed at the beginning of the trial and at the end of each treatment period.<br />

rEsuLTs: The PCSO-524 diet significantly reduced (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!